C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676)
12/2002
12/19/2002	CA2449256A1 Modulators of peroxisome proliferator activated receptors
12/19/2002	CA2445653A1 Substituted sulfonamide compounds, process for their use as medicament for the treatment of cns disorders, obesity and type ii diabetes
12/18/2002	EP1267495A1 RF receiver having cascaded filters and an intermediate amplifier stage
12/18/2002	EP1267170A1 Method for characterising polypeptides
12/18/2002	EP1266888A1 Quinoline derivatives and medicinal use thereof
12/18/2002	EP1265853A1 Carboxylic acid derivatives as ip antagonists
12/18/2002	EP1265640A1 Fluorescent membrane intercalating probes and methods for their use
12/17/2002	US6495693 N-(aryl/heteroaryl) amino acid derivatives, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
12/17/2002	US6495581 Drug for treating diabetes mellitus, hyperlipemia, impaired glucose tolerance, arterial sclerosis and improving insulin resistance, inflammatory disease
12/17/2002	US6495566 Potent antagonists at the strychnine insensitive glycine binding site associated with the n-methylaspartic acid receptor complex
12/17/2002	US6495565 For therapy of acute infection, acute phase response, age related macular degeneration, alcoholism, anorexia, asthma, autoimmune disease, autoimmune hepatitis, bechet's disease, cachexia, calcium pyrophosphate dihydrtate deposition
12/17/2002	US6495552 Treatment or prevention of the diseases and conditions which respond to treatment by retinoids and or which in healthy mammals, including humans, are controlled by natural retinoic acid.
12/17/2002	CA2061675C Quinoline-containing ketoacids as leukotriene antagonists
12/12/2002	WO2002099124A2 Characterising polypeptides
12/12/2002	WO2002098859A1 Process for preparation of a quinolinecarbaldehyde
12/12/2002	WO2002098856A2 Piperazine oxyquinoline (naphthaline) platelet adenosine diphosphate receptor antagonists
12/12/2002	WO2002098848A1 Benzoylsulfonamides and sulfonylbenzamidines for use as antitumour agents
12/12/2002	WO2002098425A1 Substituted 4-aryl-3-(3-aryl-1-oxo-2-propenyl)-2(1h)-quinolinones and analogs as activators of caspases and inducers of apoptosis and the use thereof
12/12/2002	WO2002098424A1 Novel anti-infectives
12/12/2002	WO2002098406A1 Novel compounds and compositions as cathepsin inhibitors
12/12/2002	WO2002098367A2 Hybrid 2-aminotetralin and aryl-substituted piperazine compounds and their use in altering cns activity
12/12/2002	US20020188122 Such as pyridine-4-carboxaldehyde-(4-Morpholinylprop-3-yl) imine for use in therapy as cytokine inhibitors
12/12/2002	US20020188120 Such as 4-(4-methyoxy-benzenesulfonyl)-1-(3-phenyl-propyl)-piperidine-4-carboxylic acid hydroxyamide for treatment of arthritis, tumor metastasis, tissue ulceration, abnormal wound healing, periodontal disease, bone diseases, diabetes, and HIV
12/12/2002	US20020187983 Process for the synthesis of derivatives of 2, 3-dihydro-1, 4-dioxino- [2, 3-f] quinoline
12/12/2002	CA2449942A1 Characterising polypeptides
12/12/2002	CA2449770A1 Novel anti-infectives
12/12/2002	CA2449021A1 Novel compounds and compositions as cathepsin inhibitors
12/12/2002	CA2446719A1 Benzoylsulfonamides and sulfonylbenzamidines for use as antitumour agents
12/11/2002	EP1264827A1 Process for the preparation of Tosylbenzylformamides
12/11/2002	EP1264820A1 Novel amide compounds
12/11/2002	EP1263756A2 Beta-amino acid derivatives as inhibitors of matrix metalloproteases and tnf-alpha
12/11/2002	EP1263755A2 Cyclic beta-amino acid derivatives as inhibitors of matrix metalloproteases and tnf-alpha
12/11/2002	EP1263733A2 Derivatives of quinoline as alpha-2 antagonists
12/11/2002	EP1263716A2 Amino acid derivatives as hiv aspartyl protease inhibitors
12/11/2002	EP1263503A2 Use of cyanoquinolines for treating or inhibiting colonic polyps
12/11/2002	EP1100805B1 Medicine nitrate salts
12/11/2002	EP0966436B1 Aryl sulfonamides and analogues thereof and their use in the treatment of neurodegenerative diseases
12/11/2002	EP0805796B1 Cell adhesion inhibitors
12/11/2002	EP0752813B1 Inhibitors of metazoan parasite proteases
12/11/2002	EP0624155B2 Carbamates and plant-protecting agents containing them
12/11/2002	CN1095834C Quinolinone derivatives and antianaphylactic agent containing said quinolinone derivative as biological active component
12/10/2002	US6492517 The present invention relates to a method for preparing 5- and 6-halomethyl quinoxalines in presence of a radical initiator in a solvent selected from the group consisting of fluorobenzene, difluorobenzenes, trifluorobenzenes,
12/10/2002	US6492412 Prevention of loss and restoration of bone mass by certain prostaglandin agonists
12/10/2002	US6492393 Compounds useful as anti-inflammatory agents
12/10/2002	US6492390 Treating cyclooxygenase-2 mediated disorders.
12/10/2002	US6492373 6-fluoro-1,4-dihydro-7-[4-(2-hydroxyiminoethyl)-1-piperazinyl]-4-oxoquinoline-3-carboxylic acid derivatives, their preparation and pharmaceutical compositions
12/10/2002	US6492368 Benzamidine derivatives as factor XA inhibitors
12/10/2002	US6492362 Compounds and compositions as cathepsin S inhibitors
12/09/2002	WO2002004403A1 Biphenylcarboxylic acid amides, production thereof and use thereof as medicaments
12/09/2002	CA2412116A1 Biphenylcarboxylic acid amides, the preparation thereof and the use thereof as medicaments
12/05/2002	WO2002096903A2 Chemical derivatives and the use thereof as an anti-telomerase agent
12/05/2002	WO2002096879A1 Aminoquinoline and aminopyridine derivatives and their use as adenosine a3 ligands
12/05/2002	WO2002096869A2 Piperazine mono(dithio)carbamate ester compounds and analogs thereof
12/05/2002	WO2002096858A1 Cinnamide derivatives as kcnq potassium channel modulators
12/05/2002	WO2002096516A1 Use of compositions comprising cyclooxygenase-2 selective inhibitors in combination with radiation for inhibition or prevention of cardiovascular disease
12/05/2002	WO2002096424A1 Hetereocyclic beta-aminoacids and their use as anti-epileptogenic agents
12/05/2002	US20020183342 For use as insecticides against a variety of insects, including larvae, such as tobacco budworm
12/05/2002	US20020183321 Carbocyclic and heterocyclic substituted semicarbazones and thiosemicarbazones and the use thereof
12/05/2002	CA2448894A1 Cinnamide derivatives as kcnq potassium channel modulators
12/05/2002	CA2448160A1 Heterocyclic beta-amino acids and their use as anti-epileptogenic agents
12/05/2002	CA2447657A1 Use of compositions comprising cyclooxygenase-2 selective inhibitors in combination with radiation for inhibition or prevention of cardiovascular disease
12/04/2002	EP1262477A1 Anti-acid-fast bacterial agents containing pyridonecarboxylic acids as the active ingredient
12/04/2002	EP1262476A1 Processes for preparing quinoline derivatives and intermediates thereof
12/04/2002	EP1261579A1 Dehydroamino acids
12/04/2002	EP1261321A2 Carboxylic acid amides, medicaments containing these compounds and the use and production thereof
12/04/2002	EP1097139B1 Quinoline derivatives
12/04/2002	EP0815124B1 Heterocyclecarbonyl amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
12/04/2002	CN1383424A Aryl and heteroacrylcyclopropyl oxime ethers and their use as fungicides
12/03/2002	US6489479 Process for the preparation of mixed anhydrides
12/03/2002	US6489478 4-amino substituted-2-substituted-1,2,3,4-tetrahydroquinolines
12/03/2002	US6489475 Method of producing heterocyclic derivatives
12/03/2002	US6489339 C3A receptor ligands
11/2002
11/28/2002	WO2002094809A1 3-quinoline-2-(1h)-ylideneindolin-2-one derivatives
11/28/2002	WO2002094799A2 Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues
11/28/2002	WO2002094789A1 Quinoline derivatives as ligands for the neuropeptide y receptor
11/28/2002	WO2002094788A1 2-substituted 1,2,3,4-tetrahydroquinolines and derivatives thereof, compositions and methods
11/28/2002	WO2002094770A2 Aminoalcohol derivatives
11/28/2002	WO2002094268A1 Tetrahydroquinolin derivatives for the inhibition of diseases associated with estrogen deprivation or with an aberrant physiological response to endogenous estrogen
11/28/2002	WO2002094261A1 Cxcr4-antagonistic drugs comprising nitrogen-containing compound
11/28/2002	WO2002094203A2 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
11/28/2002	WO2002094187A2 Novel use
11/28/2002	US20020177716 Intermediates of CETP inhibitors
11/28/2002	US20020177715 Quinone-indicator antibiotics; controlling gene expression
11/28/2002	US20020177637 Polymers and oligomers, their synthesis, and electronic devices incorporating same
11/28/2002	US20020177601 Inhibit the signal transduction by tyrosine kinases; e.g. 4-(3-chloro-4-fluorophenylamino)-6-(3-(4-(methoxycarbonyl-methyl)-1 -piperazinyl)propyloxy)-7-methoxyquinazoline; use such as antitumor agent
11/28/2002	US20020177594 Inhibitors of histone deacetylase
11/28/2002	US20020177588 Selectivity
11/28/2002	US20020177587 Treating sexual dysfunction including erectile dysfunction, diabetes melitus, gastrointestinal disorders, including gastric paresis and cardiovascular disorders; cyclic guanosine 3',5'-monophosphate (cGMP)
11/28/2002	US20020177559 Inhibitors of cellular efflux pumps of microbes
11/28/2002	CA2448080A1 Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues
11/28/2002	CA2448076A1 3-quinoline-2-(1h)-ylideneindolin-2-one derivatives
11/28/2002	CA2447103A1 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
11/28/2002	CA2447063A1 Novel use
11/28/2002	CA2446324A1 Quinoline derivatives as ligands for the neuropeptide y receptor
11/28/2002	CA2444787A1 Tetrahydroquinolin derivatives for the inhibition of diseases associated with estrogen deprivation or with an aberrant physiological response to endogenous estrogen
11/27/2002	EP1259497A1 Novel quinoline ligands and metal complexes for diagnosis and therapy
11/27/2002	EP1259488A1 Ortho-sulfonamido aryl hydroxamic acids, process for their preparation and their use as matrix metalloproteinase inhibitors
11/27/2002	EP1073639B1 Quinoline derivatives
11/27/2002	EP0862557B1 SYMMETRICAL bis-HETEROARYLMETHOXYPHENYLALKYL CARBOXYLATES AS INHIBITORS OF LEUKOTRIENE BIOSYNTHESIS
11/27/2002	CN1382124A Bicycle androgen and progesterone receptor modulator compounds and methods

1 ... 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 ... 277